<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04696900</url>
  </required_header>
  <id_info>
    <org_study_id>REHAB-HF/VAD</org_study_id>
    <nct_id>NCT04696900</nct_id>
  </id_info>
  <brief_title>Effect of Prescribed Cardiac Rehabilitation in Patients With Advanced Heart Failure or Ventricular Assist Device</brief_title>
  <official_title>Examination of the Effect of Prescribed Cardiac Rehabilitation on Quality of Life, Exercise Capacity and Course of Disease in Patients With Advanced Heart Failure or After Ventricular Assist Device Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>German Heart Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will evaluate the effect of prescribed exercise training on quality of life and&#xD;
      exercise capacity of patients with advanced heart failure or after ventricular assist device&#xD;
      implantation. Furthermore, clinical, laboratory and echocardiographic markers of heart&#xD;
      failure, rehospitalization rates and cost-effectiveness will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of exercise training in severe heart failure as assessed by quality of life</measure>
    <time_frame>after 3, 6 and 12 months</time_frame>
    <description>Change of quality of life by Kansas City Cardiomyopathy Questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of exercise training in severe heart failure as assessed by exercise capacity</measure>
    <time_frame>after 3, 6 and 12 months</time_frame>
    <description>Change of exercise capacity measured by six-minute walking distance in meters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rehospitalization rates</measure>
    <time_frame>12 months before training and 12 months while training</time_frame>
    <description>Change in rehospitalization rate or unplanned outpatient healthcare visits due to symptoms of heart failure measured by a final visit and record screening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart failure biomarkers</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change in biomarkers of heart failure: NTproBNP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function biomarker: Creatinin</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change in biomarkers of renal function: creatinin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function biomarkers: glomerular Filtration rate</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change in biomarkers of renal function: glomerular filtration rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic function biomarkers: transaminases</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change in biomarkers of hepatic function: transaminases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic function biomarkers: gamma-glutamyltransferase</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change in biomarkers of hepatic function: gamma-glutamyltransferase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure Progression: Ejection fractions</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change of echocardiographic findings: ejection fraction (in %)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure Progression: Diameters</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change of echocardiographic findings: diameters (in mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure Progression: Aortic Valve opening</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change of echocardiographic findings: aortic valve opening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure Progression: Valvular regurgitations</measure>
    <time_frame>after 6 and 12 months</time_frame>
    <description>Change of echocardiographic findings: Valvular regurgitation (in grades I-IIIÂ°)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">14</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Exercise training</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>14 participants will absolve a prescribed exercise training for 12 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>exercise training in an approved rehabilitation program</description>
    <arm_group_label>Exercise training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt;17 years&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
          -  chronic end-stage systolic heart failure with or without ventricular assist device&#xD;
&#xD;
          -  clinically stable for at least 6 weeks&#xD;
&#xD;
          -  prescription of cardiac rehabilitation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  addictions or other illnesses that impact the ability to understand the nature, scope&#xD;
             and consequences of the trial&#xD;
&#xD;
          -  lack of knowledge of German to fully understand study information&#xD;
&#xD;
          -  pregnancy, pre-menopausal women&#xD;
&#xD;
          -  participation in the rehabilitation program &lt; 80%&#xD;
&#xD;
          -  contraindications of cardiopulmonary exercise testing on an ergometer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>I A Just</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>F Schoenrath</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Heart Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>I A Just</last_name>
    <phone>00493045932025</phone>
    <email>ijust@dhzb.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>F Schoenrath</last_name>
    <phone>00493045932085</phone>
    <email>schoenrath@dhzb.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Heart Institute</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I A Just</last_name>
      <phone>00493045932025</phone>
      <email>ijust@dhzb.de</email>
    </contact>
    <contact_backup>
      <last_name>F Schoenrath</last_name>
      <phone>00493045932085</phone>
      <email>schoenrath@dhzb.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>advanced heart failure</keyword>
  <keyword>ventricular assist device</keyword>
  <keyword>exercise training</keyword>
  <keyword>cardiac rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

